| Date Filed | Type | Description |
| 10/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
4
| Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 27,890 shares
@ $61.15, valued at
$1.7M
Sold 22,110 shares
@ $61.6, valued at
$1.4M
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 17,369 shares
@ $0
Granted 11,578 shares
@ $0 |
|
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 13,460 shares
@ $0
Granted 1,332,620 shares
@ $0 |
|
| 11/23/2021 |
3
| Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 3 on ANI PHARMACEUTICALS INC |